News & Updates

The June 2012 NICHD Research Perspectives—NICHD' monthly podcast series—features discussions of a treatment that reduces the body temperatures of infants who experience oxygen deficiency at birth, the effectiveness of progesterone as a treatment for the infertility associated with polycystic ovary syndrome, and the influence that engaging the attention of young children with autism has on their language development.

One of the basic elements of cognition―the ability to estimate quantities―grows more precise across the first 30 years or more of a person’s life, according to researchers supported by the National Institutes of Health.

According to the Centers for Disease Control and Prevention (CDC), birth defects occur in one of every 33 babies and are the leading cause of infant death. These problems, present at birth, are caused by genetics, the environment, and other known and unknown causes. Environmental causes of birth defects include chemical and other exposures that occur during pregnancy, including exposure to alcohol and drugs.

An intervention in which adults actively engaged the attention of preschool children with autism by pointing to toys and using other gestures to focus their attention results in a long term increase in language skills, according to researchers supported by the National Institutes of Health.

About 1 million newborn babies around the world die each year from birth asphyxia—a lack of oxygen to the brain—in the moments before, during, and right after birth, according to the World Health Organization. Often these deaths occur in areas where resources and access to technology is limited.

Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.

Children exposed to HIV in the womb may be more likely to experience hearing loss by age 16 than are their unexposed peers, according to scientists in a National Institutes of Health research network.

Surgery to repair pelvic organ prolapse often carries a risk of incontinence. To avoid scheduling a second surgery, some women may opt to have a second procedure to reduce incontinence at the time of their prolapse repair surgery.

Young men being treated for HIV are more likely to experience low bone mass than are other men their age, according to results from a research network supported by the National Institutes of Health. The findings indicate that physicians who care for these patients should monitor them regularly for signs of bone thinning, which could foretell a risk for fractures. The young men in the study did not have HIV at birth and had been diagnosed with HIV an average of two years earlier.

According to the Centers for Disease Control and Prevention (CDC), infertility affects about 12% of all people of reproductive age—women and men—in the United States attempting to get pregnant. Other estimates suggest that the numbers are even higher

Secretary Sebelius addressed the researchers at the Network's Annual Steering Committee meeting this month. The Network, established by the NICHD and the Bill and Melinda Gates Foundation, seeks to prevent maternal and infant deaths and illnesses worldwide. Scientists from developing countries, together with those in the United States, lead teams that identify the health needs of an area and address those needs through randomized clinical trials to test treatments and interventions.

Secretary Kathleen Sebelius (l) recently recognized Dr. Anthony Rene at the HHS offices in Washington, D.C., for 50 years of federal service.

Children's health and human development includes more than just physical and physiological changes. Mental and emotional health and well-being are as important to a child's development. Such factors as exposure to violence, parental occupation and stress, special health care needs, injuries, and exposure to illicit and prescription drugs can have long-lasting effects on children. Addressing the needs of children with or at-risk for mental or emotional health issues can help improve their quality of life through adolescence and adulthood.

A treatment to reduce the body temperatures of infants who experience oxygen deficiency at birth has benefits into early childhood, according to a follow-up study by a National Institutes of Health research network.

Transcript of an audio news briefing about Newborn Hypothermia Treatment.

This month, the institute launched NICHD Research Perspectives, a new podcast series. Each month, NICHD Director Alan E. Guttmacher will talk with NICHD scientists and program staff about findings from their areas of expertise. The series provides a means for researchers to go beyond the descriptions in news releases, to discuss the implications of the research, what the findings may mean for patients and members of the public, as well as what direction future studies might take.

During their lifetimes, many women will face a wide array of health issues. Some will seek treatment for gynecological conditions, such as endometriosis and uterine cancer. Others will experience conditions that affect both males and females, but that follow a different course in women, such as heart disease. Women's health is also affected by factors like socioeconomic status and race/ethnicity, sometimes in ways that they cannot control directly.

The Society for Clinical Trials (SCT) has selected the NICHD Management of Myelomeningocele Study (MOMS) as its 'Trial of the Year.'

The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by a National Institutes of Health research network.

In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own – for the first time in nearly 15 years – by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety and feasibility of an investigational device called the BrainGate neural interface system. This is a type of brain-computer interface (BCI) intended to put robotics and other assistive technology under the brain's control.